Fluspirilene and mefloquine share 2 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.024 means 2% of the combined target set is bound by both compounds. The IDF-weighted score of 0.023 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
What do Fluspirilene and mefloquine have in common?
Fluspirilene and mefloquine share 2 molecular targets with a Jaccard similarity of 2%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can Fluspirilene and mefloquine be combined?
Fluspirilene and mefloquine share 2 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: Fluspirilene or mefloquine?
Both Fluspirilene and mefloquine have substantial PubMed research. View their individual profiles for full evidence scores.